The present invention relates to compounds of formula I, which are functionalized phenolic compounds, and polymers formed from the same.
Ar—[O—(X)p—R′]q I
Polymers formed from the functionalized phenolics are expected to have controllable degradation profiles, enabling them to release an active component over a desired time range. The polymers are also expected to be useful in a variety of medical applications.
本发明涉及式I的化合物,它们是功能化酚类化合物,以及由它们形成的聚合物。
Ar—[O—(X)p—R′]q I
从功能化酚类化合物形成的聚合物预计具有可控的降解特性,使它们能够在所需的时间范围内释放活性成分。这些聚合物还预计在各种医疗应用中有用。
ANTI-VIRAL COMPOUNDS
申请人:Iadonato Shawn P.
公开号:US20110262482A1
公开(公告)日:2011-10-27
Disclosed herein are compounds and related compositions for the treatment of viral infection, including RNA viral infection, and compounds that can modulate the RIG-I pathway in vertebrate cells, including compounds that can activate the RIG-I pathway.
Functionalized phenolic compounds and polymers therefrom
申请人:Bezwada Biomedical, LLC
公开号:US08802892B2
公开(公告)日:2014-08-12
The present invention relates to compounds of formula I, which are functionalized phenolic compounds, and polymers formed from the same.
Ar—[O—(X)p—R′]q I
Polymers formed from the functionalized phenolics are expected to have controllable degradation profiles, enabling them to release an active component over a desired time range. The polymers are also expected to be useful in a variety of medical applications.